About 9 results found for searched term "c-Myc inhibitor 7" (0.122 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M45299 | c-Myc inhibitor 7 | Casein Kinase |
| c-Myc inhibitor 7 is a c-Myc inhibitor and multi-targeted protein degrader. c-Myc inhibitor 7 effectively degrades c-Myc, CK1α, GSPT1 and IKZF1/2/3 proteins in a variety of tumor cells. It can also be used in the study of diseases with high c-Myc expression. | ||
| M1679 | BIIB021 | HSP |
| CNF2024 | ||
| BIIB021 (CNF2024) is an orally available synthetic non-ansamycin Hsp90 inhibitor with ki value of 1.7nM. | ||
| M11180 | (+)-(3R,8S)-Falcarindiol | Antibiotic |
| (3R,8S)-Falcarindiol; 3(R),8(S),9(Z)-Falcarindiol | ||
| (+)-(3R, 8S)-Falcarindiol is polyacetylene obtained from carrots, has an antimycobacterial effect, the lowest inhibitory concentration of Mycobacterium tuberculosis H37Ra MIC and IC50 The values are 24 μM and 6 μM, respectively. Has anti-tumor and anti-inflammatory effects. | ||
| M11420 | MYCi975 | c-Myc |
| NUCC-0200975 | ||
| MYCi975 (Nuc-0200975) is an orally active MYC inhibitor that disrupts MYC/MAX interactions, promotes MYC T58 phosphorylation and MYC degradation, and impairs myC-driven gene expression. MYCi975 (NUC-0200975) has strong anti-tumor effect and good tolerance, increasing tumor immune cell infiltration and enhancing tumor sensitivity against PD1 immune studies. | ||
| M11543 | VPC-70619 | c-Myc |
| Vpc-70619 is a potent oral active n-myC inhibitor. Vpc-70619 inhibits the binding of n-MyC-Max complex to DNA e-box and exhibits strong inhibitory activity against N-MyC-dependent cell lines and high bioavailability for oral and intrabitoneal administration. | ||
| M17545 | Vibralactone D | Sesquiterpenoids |
| Vibralactone D is a metabolite isolated and cultured from a naturally occurring ascomycete and exhibits weak inhibitory activity (IC50 85.7 μM) against the isoenzyme of 11b-hydroxysteroid dehydrogenase (HSD). | ||
| M28206 | Actinonin | Aminopeptidase |
| (-)-Actinonin | ||
| Actinonin ((-)-Actinonin) is a naturally occurring antibacterial agent produced by Actinomyces. Actinonin inhibits aminopeptidase M, aminopeptidase N and leucine aminopeptidase. Actinonin is a potent reversible peptide deformylase (PDF) inhibitor with a Ki of 0.28 nM. Actinonin also inhibits MMP-1, MMP-3, MMP-8, MMP-9, and hmeprin α with Ki values of 300 nM, 1,700 nM, 190 nM, 330 nM, and 20 nM, respectively. Actinonin is an apoptosis inducer. Actinonin has antiproliferative and antitumor activities. | ||
| M28689 | NITD-916 | Antibiotic |
| NITD-916, a 4-hydroxy-2-pyridone derivative, is an orally active and highly lipophilic mycobacterial enoyl reductase InhA inhibitor with an IC50 of 570 nM. NITD-916 forms a ternary complex with InhA and NADH to block access to the fatty acyl substrate binding pocket. NITD-916 has potent anti-tuberculosis effects. | ||
| M41042 | SEQ-9 | Antibiotic |
| SEQ-9 is an orally active Mycobacterium tuberculosis (Mtb) 23S bacterial ribosome inhibitor with an IC50 of approximately 170 nM for unmethylated Mtb ribosomes. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
